| Names | |
|---|---|
| Preferred IUPAC name | 2-Hydroxy-3-(trifluoromethyl)pyridine |
| Other names | 2-Hydroxy-3-(trifluoromethyl)pyridine 3-(Trifluoromethyl)-2-pyridinol 3-(Trifluoromethyl)-2-hydroxypyridine 2-Hydroxy-3-(trifluoromethyl)pyridine |
| Pronunciation | /tuː-haɪˈdrɒk.si-θriː-traɪˌfluːrəˈmɛθɪl-pɪˈrɪd.iːn/ |
| Identifiers | |
| CAS Number | 86604-75-3 |
| Beilstein Reference | 127875 |
| ChEBI | CHEBI:196309 |
| ChEMBL | CHEMBL3216587 |
| ChemSpider | 20638775 |
| DrugBank | DB08317 |
| ECHA InfoCard | 100_113_915 |
| EC Number | NA |
| Gmelin Reference | 85544 |
| KEGG | C18606 |
| MeSH | D000077460 |
| PubChem CID | 156026 |
| RTECS number | US2439000 |
| UNII | Q7T4QRT2QH |
| UN number | UN3439 |
| Properties | |
| Chemical formula | C6H4F3NO |
| Molar mass | 161.09 g/mol |
| Appearance | Colorless to light yellow liquid |
| Odor | Odorless |
| Density | 1.378 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 0.72 |
| Vapor pressure | 0.8 hPa at 20 °C |
| Acidity (pKa) | 5.2 |
| Basicity (pKb) | 6.52 |
| Magnetic susceptibility (χ) | -53.0·10⁻⁶ cm³/mol |
| Refractive index (nD) | 1.437 |
| Viscosity | 114 mPa·s |
| Dipole moment | 2.52 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 129.2 J·mol⁻¹·K⁻¹ |
| Std enthalpy of formation (ΔfH⦵298) | -444.2 kJ/mol |
| Std enthalpy of combustion (ΔcH⦵298) | -836.7 kJ/mol |
| Pharmacology | |
| ATC code | This substance does not have an ATC code. |
| Hazards | |
| Main hazards | Irritating to eyes, respiratory system and skin |
| GHS labelling | GHS05, GHS07 |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302, H315, H319, H335 |
| Precautionary statements | P261, P280, P305+P351+P338, P337+P313 |
| NFPA 704 (fire diamond) | 1-1-0 |
| Flash point | Flash point: 89°C |
| Autoignition temperature | 440 °C |
| Lethal dose or concentration | LD₅₀ (oral, rat): >2000 mg/kg |
| LD50 (median dose) | LD50 (median dose): Oral rat LD50: > 2000 mg/kg |
| NIOSH | No OSHA PEL/TWA/NIOSH/REL/TWA found. |
| PEL (Permissible) | Not established |
| REL (Recommended) | No REL established |
| Related compounds | |
| Related compounds | 2-Hydroxypyridine 3-Trifluoromethylpyridine 2-Chloropyridine 2-Methoxypyridine 3-Chloropyridine |
| Category | Description |
|---|---|
| Product Name & IUPAC Name | 2-Hydroxy-3-trifluoromethylpyridine IUPAC Name: 2-Hydroxy-3-(trifluoromethyl)pyridine |
| Chemical Formula | C6H4F3NO |
| Synonyms & Trade Names | 3-(Trifluoromethyl)-2-pyridinol 2-Hydroxy-3-(trifluoromethyl)pyridine |
| CAS Number | 243649-46-9 |
| HS Code & Customs Classification | 2933.39 — Other heterocyclic compounds with nitrogen hetero-atom(s) only; excluding fused ring compounds Final 6- or 8-digit determination depends on local regulations and intended use. |
This pyridine derivative requires monitored handling and processing across each production stage. Sourcing of starting materials for the trifluoromethyl group and hydroxy substitution must be controlled for reactivity consistency and traceability. The selection between electrophilic versus nucleophilic trifluoromethylation directs not only overall process efficiency but also influences final impurity profiles—chlorinated or brominated side-products can arise if halogen precursors are involved, requiring refined purification strategies at downstream stages.
Batch consistency management sits on analytical feedback: raw material purities, in-process conversion yields, and hydrolyzable by-products fluctuate with both solvent choice and batch-to-batch temperature control. Typical values for by-product loads or residual solvents depend on both route and final grade. Pharmaceutical and agrochemical applications call for tighter limits and multi-stage refinement, whereas technical or intermediate grades are defined by internal standards negotiable against customer formulation requirements. Storage stability is substantially affected by the absence or presence of trace acid/base contaminants, as the hydroxy group can undergo gradual transformation or discoloration if exposed to atmospheric moisture or acidic packaging.
In-process control focuses on endpoint determination for pyridine ring substitution, using chromatographic and spectroscopic confirmation in parallel. Critical recovery points lie in the separation of regioisomers and the removal of fluoride-rich inorganic phases. Final release standards defer to customer specification: whether for an API intermediate, crop protection formulation, or for specialty chemical synthesis. The HS code is assigned according to composition and downstream use, with the 2933.39 code typically held for such non-fused pyridine analogues; site-specific classification may be re-reviewed by compliance staff if further chemical derivatization is performed.
2-Hydroxy-3-trifluoromethylpyridine typically presents as a crystalline solid or sometimes as a granular powder, with a coloration that ranges from off-white to pale yellow depending on synthesis impurities and lot age. Some batches may show a faint, characteristic aromatic odor linked to trace pyridine derivatives. Melting and boiling points are subject to the grade and residual solvent content. Industrial lots handled under containment may retain minor solvent residues, which can depress melting onset slightly. Density varies with compaction during drying and any retained crystallization solvents. Color, odor, and physical consistency may shift in response to process changes, particularly during scale-up or when transitioning between synthetic routes.
In standard production environments, 2-Hydroxy-3-trifluoromethylpyridine shows minimal reactivity at room temperature and ambient humidity, though contact with strong bases or oxidizing agents can result in rapid transformation or by-product formation. Thermal stability holds up under moderate temperature excursions common during drying or distillation, but may degrade with prolonged exposure to strong acids, complicating purification if acidic residuals are not tightly monitored. Purity impacts resistance to hydrolysis; batches with residual halide or acidic impurities display more rapid discoloration or viscosity changes in solution.
Solubility varies with water content and grade. Higher-purity crystals typically dissolve well in polar aprotic solvents (e.g., DMSO, DMF, acetonitrile), but may show partial solubility in water, with precipitation on standing if the pH is not stabilized. For formulation work, solution clarity, color, and sediment formation serve as quality markers—variability in dissolution reflects lot-dependent trace impurity or salt content. Operators monitor solution pH and temperature to avoid localized precipitation in process solutions, particularly for downstream derivatization steps.
Specifications are set based on target application—pharmaceutical and agrochemical intermediates call for stricter limits on residual solvents, trace metals, and color, while technical or catalyst-grade product may tolerate minor additional impurity bands. Actual test limits and parameters, including purity by HPLC or GC, water by Karl Fischer, and single impurity peaks, are defined on a customer- and application-specific basis. Parameter scope expands for regulated markets with attention to extractables and leachables.
Key impurities stem from over- or under-reaction during the trifluoromethylation step, incomplete hydrolysis, or adventitious by-products from raw materials. Lot history and batch-to-batch trend analysis inform impurity threshold setting, with attention paid to the carryover from recycled solvents or cross-contamination risks in multi-use plants. Internal control protocols focus on reducing side-products with similar polarity, which complicate purification during chromatographic steps.
Routine release testing utilizes validated HPLC-UV or GC-FID methods, supplemented by mass spectroscopy for detailed impurity mapping, and potentiometric titration for acidic/basic by-products. Depending on the regulatory destination, confirmation against pharmacopeial, company, or client-specific protocols is enforced. Any deviation triggers a batch investigation before release; internal reference standards and trend charts form part of each lot's certificate of analysis.
Raw material selection hinges on trifluoromethyl source quality and the pyridine backbone's lot consistency. Sourcing from ISO-audited suppliers reduces variability in starting halide content and trace metal burden. Alternative routes exist depending on raw material economics and regulatory requirements, especially when adapting for REACH or other international chemical registrations.
Producers employ either direct trifluoromethylation of 2-hydroxypyridine or a stepwise sequence involving nucleophilic substitution and selective hydrolysis. Route selection weighs cost, raw material volatility, and scalability, with some sites standardizing on safer non-metallic reagents if cross-contamination with heavy metals is an issue in the facility. The central mechanism proceeds through electrophilic addition at C-3 of the pyridine ring, with hydrolysis yielding the hydroxy substituent—side-reactions with water or acid scavengers are mitigated by careful feedstock control.
Temperature, pH, and feed rates rank among the chief control points to restrict by-product build-up and runaway side-reactions. Downstream, solvent selection and sequence of washes govern partitioning of impurities—trace bases or incomplete conversions may require additional acid-base extraction or column purification. Analytical monitoring during workup determines whether a lot follows full, partial, or rework purification.
Quality systems require that each batch meets not only finished product specs but also intermediate checkpoints, such as in-process sample analytics and critical impurity thresholds. Batch-to-batch consistency is checked using trend analyses of representative test parameters. Final batch release codes rely on laboratory confirmation, stability assessment, and review of all process control records for that lot. Custom release criteria can integrate client-specific additional data points.
2-Hydroxy-3-trifluoromethylpyridine is primarily a building block for further derivatization; the hydroxy site enables etherification, esterification, or alkylation, while the trifluoromethyl group endows downstream products with significant electron-withdrawing power. Electrophilic aromatic substitution and metal-catalyzed cross-coupling remain viable for more complex modification.
Optimal downstream reactions depend on base strength and solvent polarity. Common catalysts include transition metal complexes or phase-transfer agents for cross-couplings or oxidative couplings. Typical processing occurs under inert atmosphere to prevent hydroxy group oxidation, with moderate heating as necessary for slow-forming derivatives. Buffering may be required to avoid degradation during sensitive reactions.
The molecule often forms the core for pharmaceutical intermediates, advanced agrochemical agents, or specialty ligands. Downstream chemistry exploits both the hydroxy reactivity and the electronic influence from the trifluoromethyl group, allowing tight control over selectivity and final product physicochemical profile.
Industrial storage avoids high heat, humidity, and direct light exposure. Central storage areas favor closed, inert-atmosphere bins or moisture-resistant drums, monitored for temperature excursions during warehouse transit. For sensitive grades, further nitrogen purge or vacuum-sealed containment helps preserve color and limits hydrolysis.
Recommended storage involves high-density polyethylene or fluoropolymer-lined stainless steel; bare steel or aluminum increases contamination and degradation risks. Product transferred via non-reactive, dedicated lines avoids cross-contamination with strong acids, bases, or oxidants present elsewhere in the facility.
Signs of degradation include darkening, clumping, or the emergence of irritating off-odors. Shelf life tracks with exposure to air, moisture, and handling environment; specification-compliant shelf life is only assignable after thorough accelerated and real-time stability trials. Unopened factory packaging better preserves internal quality over time.
Most production batches require labeling for acute toxicity and eye/skin irritation risk under GHS criteria, though exact classification adapts with regulatory region and impurity spectrum. Finished product handling follows both facility safety standards and evolving regional guidelines.
Operators receive mandatory PPE training due to potential toxicity and reactivity with acids or bases. Plant SOPs enforce use of eye and respiratory protection in all open handling or transfer operations. Direct skin or eye contact, as well as inhalation of powders, prompt decontamination and health monitoring based on exposure scenarios developed in process risk assessments.
Available data highlight moderate acute toxicity; systemic effects track with dose and route. Chronic exposure or mishandling—especially for unrefined industrial grades—may exacerbate respiratory or irritation symptoms. Each facility builds its own occupational health management program based on in-house industrial hygiene study trends.
Absence of internationally harmonized OELs (occupational exposure limits) for this molecule pushes each operation to adopt process-specific internal limits, relying on air monitoring and personal sampling for compliance. Material transfer and dispensing systems feature local exhaust ventilation and closed containment, limiting routine airborne concentration below internal risk-based action levels.
Typical production capacity for 2-Hydroxy-3-trifluoromethylpyridine depends on both plant design and campaign scheduling. For custom synthesis projects or pharmaceutical grade orders, limited reactor space constrains batch frequency. Commodity grades support larger batch sizes, with output tied to continuous demand for agrochemical, intermediate, or pilot pharmaceutical runs. Availability across grades is directly affected by campaign allocation, inventory management policy, and the lead time for specific purification steps. Availability for specialty or higher purity grades may be restricted by necessary analytical release times and the upstream supply of starting materials.
Lead time shows strong dependence on the grade, order volume, and customer's COA/testing requirements. Standard-grade materials in inventory usually require short notice for dispatch; high-purity or tightly specified pharmaceutical grades may require manufacturing-to-order, which can extend lead time due to complex analytics and batch-specific documentation. For standard grades, minimum order quantity aligns with reactor charge size and packaging economics. High-purity or custom-certified batches generally require higher minimum orders to justify dedicated cleanup, analytical release, and shipment under special conditions.
Packaging varies according to purity, end use, and safety needs—ranging from fluoropolymer drums or lined steel containers for bulk grades to smaller amber glass bottles or high-barrier polyethylene for limited-quantity or controlled environment shipments. Packaging is selected to ensure chemical stability during storage and transit, with additional attention to regulatory compliance for dangerous goods as required by local jurisdiction.
Shipping method is aligned with hazard classification and end-user requirements. Air or sea routes are both feasible, provided compliance with international transport regulations for fluorinated intermediates. Payment terms are typically negotiated in the context of industry practice, contract volume, and credit arrangements—pre-payment or net terms are both possible for regular volume customers with established purchasing history.
For 2-Hydroxy-3-trifluoromethylpyridine, the price composition centers on several volatile raw materials: specifically, trifluoromethylation reagents, pyridine derivatives, and purification solvents. Cost swings trace chiefly to upstream fluorination reagent markets—whose volatility stems from fluorine derivative tightness, changes in environmental regulation on fluorinated compounds, and energy prices related to distillation or solvent recovery.
The primary drivers behind price shifts include fluorochemical feedstock price changes, regulatory actions challenging the use of certain pyridine intermediates, and logistical disruptions impacting hazardous chemical transport. In some cases, force majeure events at key fluorination plants can lead to cascading spot market effects.
Price tiers flow from required grade and customer end-use rather than physical lot size alone. Technical (industrial) grade material commands lower pricing by tolerating broader impurity windows. Higher prices for pharmaceutical or electronic grades reflect increased labor and analytic intensity, trace impurity control, packaging upgrades, and batch-by-batch certification. Certification for compliance with GMP, ICH Q7, or REACH registration also adds to the final cost because of the additional documentation, testing, and legal liabilities assumed by the manufacturer.
Most global demand concentrates in agrochemical intermediate, pharmaceutical, and research sectors, with downstream markets shifting geographically based on generic drug production cycles and agrochemical campaign timing. Supply bottlenecks surface periodically when either fluorination reagent supply tightens or significant regulatory shifts restrict logistics for key precursor chemicals.
In the US and EU, regulatory scrutiny surrounding both fluorinated intermediates and pyridine derivatives prompts stricter controls and lengthier qualification processes, particularly for pharmaceutical applications. Japan’s market focuses on electronic and high-end pharmaceutical grades, demanding enhanced batch consistency and tighter impurity profiles, with cost premiums due to local analytical expectations. India and China serve as both major manufacturing bases and growing end-use markets, leveraging lower conversion costs but encountering raw material volatility and occasional export restrictions. Fluctuations in Chinese feedstock or environmental regulatory action produce amplified ripple effects on global transfer prices.
Forecasts for 2026 caution around continued instability in upstream fluorochemical supply and growing costs for environmental compliance, particularly around emissions of fluorinated byproducts. Expect mid-term pressure for price increases in high-purity or specialty grades tied to additional certification requirements and expanded regulatory oversight in both North America and the EU. Bulk or industrial grade price movement will depend mainly on large-scale upstream cost trends and international logistics efficiency.
Market analysis draws on transaction data from regional chemical industry monitoring, industry association bulletins, customs reporting, and raw material price tracking platforms. Where proprietary details are required, internal batch cost audits and historical shipping records supplement regional trend models. Analysis privileges firsthand manufacturer production experience to evaluate cost drivers, batch consistency, and real-world supply disruption frequency.
Over the past twelve months, several jurisdictions have undertaken public consultation on tightening emissions limits for organofluorines and pyridine derivatives. Enforcement actions at third-party waste handling plants highlight risk to operators relying on external purification or byproduct treatment services.
New rules from EU authorities on REACH registration demand greater impurity disclosure and audit trails for specialty fluorinated intermediates, increasingly impacting pharmaceutical and high-end research supply chains. US-based changes focus on transport compliance for hazardous goods, driving manufacturers to review packaging and labeling protocols routinely.
Manufacturers have enhanced in-process control, raw material batch traceability, and secondary purification capability in response to new audit and compliance expectations. Internal QA labs deploy additional screening, with stronger focus on non-targeted impurity analysis using sensitive chromatographic methods. Facility upgrades roll out in plant segments most exposed to regulatory scrutiny, primarily where aqueous or gaseous fluorinated waste poses compliance challenges. Ongoing dialogue with customers over COA customization and packaging adaptation continues as both regulatory and user requirements shift.
2-Hydroxy-3-trifluoromethylpyridine serves as an intermediate in agrochemical, pharmaceutical, and specialty material synthesis. Most demand comes from crop protection synthesis and active pharmaceutical ingredient (API) precursors. It also fits into niche applications, including electronics intermediates where high purity is critical for process yield.
Pharmaceutical customers track isomeric and metal content closely due to downstream purity requirements. Agrochemical manufacturers typically work with several technical grades but direct material to specific processes based on side product profile. Electronics formulators inspect not only residual organics but also halide background and solvent residue.
| Application Area | Recommended Grade | Key Technical Priorities |
|---|---|---|
| Pharmaceutical Synthesis | High Purity, Low Metal Grade | Organics purity; residual metals; low water |
| Agrochemical Synthesis | Technical Grade, Customizable on Request | Total purity; known by-product signature aligned to process compatibility |
| Electronic Materials | Ultra-High Purity (if available) | Trace halide, residual solvent, particulate level; batch-to-batch reproducibility |
Pharmaceutical users review residual solvent profile and elemental impurity pattern, focusing on catalytic residue from synthesis steps. Water content impacts crystallization and isolation steps, making tight control essential. Isomer ratio and related impurity formation become critical at higher complexity levels.
Agrochemical clients primarily assess total purity and byproducts, adjusting downstream formulations to accommodate residuals when within specifications agreed per project.
Electronic formulation relies on reliable trace metal screening, halide mapping, and contamination tracking through ICP and IC methods—the tolerance windows here are established via validation with the receiving process.
Clarify end use and regulatory exposure. For API or formulation uses, set the traceability and documentation standards needed. When the material feeds into custom synthesis, communicate the specific synthesis transformation route in use—some grades match certain catalytic or workup conditions more efficiently.
APIs and precursors heading to regulated markets require supporting documentation for individual impurity control and batch traceability. Agricultural users often have to match their specifications to downstream product registrations. Electronics materials may need documentation of a wider impurity survey relevant for export certifications.
Match total and individual purity targets with the most critical product characteristic for the step in question. For pharma, individual and total impurity cutoff takes priority, including LC/MS and GC/MS traces. In crop synthesis, compatibility of the byproduct profile with the main actives matters most. For electronic uses, total ion content routinely limits acceptable lots—our lab can support with extended screening upon request.
Process economics become pronounced when annual consumption increases. Higher-purity material routes involve increased solvent use and more involved purification, raising cost and limiting available volume. Consider long-term volume trends as scale-up proceeds; technical grade is often the most sustainable for initial pilot work, followed by targeted upgrade as the project matures.
Finalize the selected grade via in-house material qualification. Our technical support team engages with customer labs to coordinate the correct sampling protocol, arranges supporting documentation, and transparently shares the batch quality dossier. Validation can include compatibility and performance in the intended process—most new projects start with a 100–500 g laboratory sample to address both analytical and synthetic performance prior to any scale commitment.
Our 2-Hydroxy-3-trifluoromethylpyridine production relies on documented quality frameworks. Internal quality systems incorporate site-wide GMP-derived protocols and ISO-compliant practices where demanded, reflecting real industrial workflows. Audits by external bodies are conducted according to customer and jurisdictional requirements, with traceable records. Audit outcomes drive process refinement, focusing on key parameters: batch reproducibility, impurity profiling, trace metal and acidic residue checks. Process deviations, out-of-spec occurrences, and lot rejection thresholds anchor the release logic.
Independent certification for this product, such as suitability for pharma synthesis, is application-driven. Routine analysis covers water content, residual solvents, and assay by validated chromatographic methods. Permitted limits can shift by customer’s downstream needs or region-specific regulatory thresholds. For electronic applications, purity and trace contaminant specs morph per end-use device—handled through customer-backed verification or third-party lab confirmation. Documentation for kosher, halal, or specific feedstock origin integrates on-demand per buyer request and regional requirements.
Standard documentation includes certificate of analysis per lot, batch release protocol, and origin declarations. Analytical results disclose methods and actual findings, as required by the purchasing program. On top of the COA, material traceability logs—spanning raw material source, batch genealogy, and process control records—are made available upon qualified request. Safety data sheets derive from current raw material hazard communication laws, tailored by region and regulatory context. End-users with special reporting needs—such as those in pharma, agro, or electronics—may require additional short-form or long-form quality summary reports, which production control teams prepare on a case-by-case basis.
Secure access to 2-Hydroxy-3-trifluoromethylpyridine grows out of predictable process scheduling and risk-mitigated raw material strategies. Production managers monitor substrate sourcing, campaign planning, and plant downtime scenarios to align output forecasts with real-order cycles. Buyers with mid- to large-volume projects can negotiate capacity assignments—either as fixed calendar-slot runs or as rolling-release agreements, depending on their inventory flow. Contractual flexibility exists for changing drawdown rates due to project seasonality or shifting technology needs, managed through quarterly or monthly review periods.
Core reactor assets serve key products with overlapping process needs, so plant utilization optimization links directly to long-term supply stability. Forward-locking of input streams, dual-validated sources for critical raw materials, and buffer stockholding protocols at intermediate stages contribute to risk reduction. Year-on-year, fluctuations in batch counts, campaign lengths, and yield variation get tracked, with capability reviews shared transparently for strategic partners who demand predictability for regulatory filings or industrial supply chains. Any interruptions in production or logistics receive documented incident reporting and rapid escalation.
Lab-scale and kilogram samples are released through a formal technical evaluation program. Requests require defined application context and target specifications so that sampling and testing align with realistic end-use conditions. Typical sample lead-times reflect campaign schedules, not just available finished goods, ensuring test lots mirror commercializable product. Non-standard grade or special purity trial batches—pharma, electronic, or agro—may involve short runs and tailored quality documentation, subject to internal risk and technical feasibility review.
Industrial procurement teams approach cooperation modes based on volume tiers, exclusivity terms, or technical qualification milestones. Core options include annual framework agreements allowing batch call-off as needed, committed volume pricing, or spot-order supplementation for peaks. Flexibility enters with tolerance for shipment cadence shifts, expedited logistics during plant turnarounds, and short-term allocation for customer validation or regulatory registration projects. For buyers running pilot programs or process scale-ups, partnerships can include collaborative data exchange, process feedback, and adaptive packaging or labeling. All flexibility mechanisms anchor to real-world production planning and technical capabilities, ensuring commercial responsiveness without jeopardizing quality or supply integrity.
Production teams in our facility report that pharmaceutical intermediates continue to drive demand for 2-hydroxy-3-trifluoromethylpyridine. Research groups focus on synthesis pathway modifications aimed at cost efficiency and impurity reduction, as process economics and purity profiles remain critical for downstream active pharmaceutical ingredients. In agrochemical labs, interest has grown for its use as a structural motif in new herbicide and fungicide candidates. Application chemists are running compatibility and reactivity screens with heterocycle builders, as the pyridine ring system lends itself to diverse derivatizations.
Technical discussions highlight its suitability for fluorinated ligand design and functional monomers for specialty polymers. Some advanced materials teams prioritize incorporation in electronic and optoelectronic development, based on the unique electronic effects from the trifluoromethyl and hydroxyl substituents. Exploration in battery electrolyte additives appears, where chemical stability and fluorine donation are relevant. Not every application requires pharmaceutical grade; electronics and materials customers work with grades tailored to their downstream formulation sensitivities.
Process chemists report that by-product control during the pyridine functionalization step presents recurring challenges. Reaction route selection depends on starting material availability and regulatory requirements, with regioselectivity and fluorination efficiency varying by route. Impurities primarily originate from incomplete hydroxylation, over-fluorination, or pyridine ring degradation. The lab teams have integrated inline spectroscopy and tighter filtration protocols, which improve lot-to-lot reproducibility. Scale-up from pilot to commercial scale requires redesign of solvent recovery and waste minimization steps; these have seen improvements through process modeling and real-time parameter tuning.
From a manufacturer’s perspective, order patterns indicate steady growth, especially from new molecule development programs in pharmaceuticals and agrochemicals. Expansion of specialty chemicals manufacturing in Asia and regulatory scrutiny in the EU shape regional demand drivers. The switch from legacy halogenated analogs to more metabolically stable trifluoromethyl-pyridine derivatives also supports upward volume trends. Sales calls expect mid- to high-single-digit annual demand growth in the next several years, subject to sectoral regulatory developments and project cycles in pharma and agro.
Process engineers continue to refine catalytic and direct fluorination routes, aiming for higher selectivity and lower emissions. Customers request custom impurity profiling and analysis, prompting investments in QA instrumentation and automation. Technological advances focus on greener solvents, energy efficiency in synthesis steps, and recovery of valuable by-products. This impacts both the product cost basis and the environmental footprint, which is growing in importance for key account buyers.
R&D leadership prioritizes greener chemical conversion routes and solvent reuse, following stricter life cycle analysis requirements from multinational customers. Batch documentation includes solvent and waste tracking, particularly where local discharge regulations require specification of organofluoride residues. Where possible, catalyst recovery and lower temperature syntheses have been introduced to limit off-gassing and improve process yield. Technical feedback loops between production and customer QA teams identify which grades and specifications support transition to more sustainable supply chains.
Our technical team provides direct consultation to R&D chemists on optimal grade selection, compatibility testing with target molecules, and process troubleshooting. Experience in batch histories, impurity trends, and analytical method selection shortens the qualification process for new projects. Documentation support includes origin of starting material, process batch records, and impurity traceability on request, tailored to end-use sector and region.
Support chemists work closely with formulators to address solubility, reactivity, and purification needs for product integration. Application guidance includes recommendations based on industrial experience handling process and material sensitivities. Where process deviations or downstream issues arise, collaborative troubleshooting includes root cause analysis, lab-scale replications, and, where necessary, process retraining on the customer’s site. Support scope varies—pharmaceutical customers require extended documentation compared to those in materials chemistry.
Production and QA teams maintain comprehensive batch records and retain samples, allowing for technical investigation and traceability if quality or performance questions arise post-delivery. Return and analysis protocols exist for complaint handling, with a focus on resolution informed by both application context and manufacturing conditions. Technical support extends to regulatory documentation, including REACH or TSCA compliance records, with periodic updates as regulations change. Internal review cycles ensure QA, QC, and production departments collaborate to fulfill evolving end-market requirements, with escalation protocols for technical cases requiring senior chemist input.
In the manufacturing of 2-Hydroxy-3-trifluoromethylpyridine, direct control over synthesis and finishing steps shapes both the product and its downstream performance in industrial use. Starting with high-purity raw materials, automated overhead reactors and controlled temperature regulation systems govern each batch. Inline analytical verification and closed-environment drying prevent cross-contamination, resulting in purity profiles meeting industry expectations for pharmaceutical intermediates, advanced agrochemicals, and specialty coatings.
Manufacturers use 2-Hydroxy-3-trifluoromethylpyridine in processes where the trifluoromethyl group’s influence on reactivity and solubility matters. This molecule supports high-performance drug synthesis requiring stable aromatic intermediates and sees consistent demand from crop science companies that engineer actives for improved environmental persistence. Electronics and polymers sectors apply the compound in research settings where material modification and surface treatments improve end-product performance.
Analytical staff oversee every stage, using HPLC and NMR authentication to verify each lot’s composition. The factory retains archived batch samples, supporting traceability and comparative studies. By holding spec ranges for each critical parameter, industrial buyers receive consistent material with proven reactivity, limiting downtime and adjustment cycles during formulation. Process feedback loops and staff intervention reduce off-spec material, safeguarding the customer’s operating schedule.
Packing lines fill steel drums, plastic kegs, or custom intermediate bulk containers based on shipment volume and handling preferences. Nitrogen-inerted packages preserve chemical integrity during transit and storage, with drum sealing protocols meeting international safety recommendations. Regular container audits verify performance after production and before dispatch. Scaled packaging routines adapt to production runs from trial lots to continuous supply, streamlining bulk processing at the customer site.
Integration of synthesis, finishing, and on-site warehousing supports short lead times and large-volume shipment schedules. Order tracking from production to delivery minimizes delays, critical for customers operating just-in-time or with seasonal manufacturing swings. Documentation links each lot to production data, simplifying procurement planning and regulatory record-keeping for downstream users.
Process engineers and technical liaison teams address scale-up questions, compatibility checks, and analytical benchmarks. On-site visits and remote troubleshooting interface directly with customer plants, helping validate new applications or optimize yields. Technical staff interpret analytical findings, recommend process modifications, and resolve queries during new project launches or requalification cycles.
Direct manufacturing and full control over supply chains reduce middlemen and uncertainty, giving procurement teams fixed supply arrangements and reliable cost structures. Product consistency and traceability simplify audits and vendor assessments. For distributors, on-time deliveries and repeatable batch quality build credibility across network partners. Manufacturers downstream cut overhead on troubleshooting and achieve more predictable product launches or process changeovers due to reproducible input quality.
At our facility, we handle 2-Hydroxy-3-trifluoromethylpyridine from initial synthesis through to final packaging and logistics, so we have a direct view of the solvent choices affecting its application and downstream use. The solubility profile of any fluorinated pyridine derivative naturally affects not only laboratory-scale formulations but also larger production setups. Over time, we have seen certain trends and technical realities emerge regarding solvent compatibility, especially with this compound.
Given the hydrophilic hydroxyl group and the strong electron-withdrawing trifluoromethyl group ortho to the nitrogen, 2-Hydroxy-3-trifluoromethylpyridine brings both hydrogen bonding and fluorinated aromatic features to the table. These features govern its interaction with common organic solvents. On our production floor, we test each batch for solubility in a range of solvents as part of our internal QC. We have seen reliable dissolution in common polar aprotic solvents such as dimethyl sulfoxide (DMSO) and N,N-dimethylformamide (DMF), which provide strong solvating power for heteroaromatic and partially polar compounds like this one. Acetonitrile, thanks to its moderate polarity, also offers suitable solubility for most workups.
In less polar environments, the limitations become clear. Ether solvents like diethyl ether and hexane display only marginal capacity for dissolving 2-Hydroxy-3-trifluoromethylpyridine at standard lab concentrations, which reflects both experience from our own reactions and reports from downstream users. Alcohols such as methanol and ethanol can dissolve moderate quantities, aided by hydrogen bonding, but beyond a moderate range, precipitation can occur during cool-down or upon standing.
For clients aiming at scale-up and optimization, avoiding water as a primary solvent generally leads to better outcomes for both product recovery and process reproducibility. In the presence of water, we typically see reduced solubility, with only minimal dispersibility or partial dissolution unless heated or combined with strong bases. This property affects purification and crystallization steps, especially when a robust and scalable process is needed.
Practical knowledge from our own manufacturing lines has shown that the quality of DMSO and DMF matters, as trace water or minor amine contaminants may cause batch-to-batch inconsistency. We source high-purity solvents and qualify them for use with this compound. For clients running sensitive synthesis, our technical team can recommend preparation techniques to ensure smooth dissolution and minimize variability. In multi-step synthetic routes involving other nucleophiles, the solvent choice with this compound can change yields and workup efficiency, so we emphasize testing with the actual batch lot before process commitment.
In application-driven projects like pharmaceutical intermediate synthesis or agrochemical research, our product’s ability to integrate with various solvent systems expands process flexibility. Downstream reactions sometimes push for solubility in less polar solvents or require stock solutions in ethanol or MeCN. We routinely support those requirements by sharing our internal data and arranging solubility screening on request, using production-scale lots as received by our customers.
Every production batch of 2-Hydroxy-3-trifluoromethylpyridine comes with unique subtleties—minor differences in polymorphic form or residual solvent content may impact dissolution rate or clarity at the outset. Our technical support team helps R&D departments address these variables upfront, so projects avoid bottlenecks or reprocessing steps later. We regularly update our internal methods database with the latest results from pilot runs, giving customers up-to-date reference points for lab-to-plant translation.
Selecting the right solvent can mean the difference between a smooth process and an expensive troubleshooting cycle. We back our production lots with technical depth and responsive support, making sure you receive not just a chemical, but actionable expertise grown on the shop floor.
Managing consistent supply for specialized intermediates like 2-hydroxy-3-trifluoromethylpyridine calls for experience not only in chemistry but in real-world logistics and production planning. Requests for this compound, particularly in bulk, have steadily increased over the past several years as the demand from agrochemical and pharmaceutical sectors expanded. We welcome these challenges because our team produces this fluorinated pyridine derivative in-house at our dedicated facility, scaling batch sizes regularly to support kilo- to multi-ton requirements.
Our routes to 2-hydroxy-3-trifluoromethylpyridine lean on robust process controls developed in close collaboration between our R&D and plant operations. We maintain dedicated reactor capacity for fluorinated heterocycles to ensure both reliability and flexibility in output. Stock positions fluctuate with seasonal upticks in downstream manufacturing and global shipping cycles, but our production scheduling centers around maintaining capacity above baseline contract volumes throughout the year. This makes bulk availability, including multiple-metric-ton orders, a realistic proposition for committed partners.
Securing reliable access to precursors like trifluoromethyl iodide and suitable pyridine derivatives forms a critical part of our strategy. We have longstanding relationships with upstream suppliers, plus regular audits and contingency reserves to side-step unexpected interruptions. Completing a campaign for large lots, especially on short notice, still relies on careful alignment between incoming materials, available labor, and downstream packaging lines. We do not outsource these steps.
Most requests for quantities in the hundreds of kilograms to low-ton scale can be serviced on standard lead times of six to ten weeks, counted from mutually agreed order confirmation and technical alignment. For very large orders or instances where concurrent large campaigns are active, lead times can stretch to twelve or more weeks, often dictated by material purification times, additional QA/QC releases, and global shipping workload. We will always reevaluate production schedules transparently to avoid over-promising—our clients depend on real timelines to plan their own operations.
Shipping in bulk presents another set of considerations: we adhere to international requirements for hazardous materials through dedicated bulk-packaging systems, including lined drums or intermediate bulk containers. Customers often ask about expedited options; we assess urgency requests case by case. Shortening lead time sometimes means prioritizing a campaign or pre-pulling raw materials, not at the cost of process integrity or safety. In-stock inventory for 2-hydroxy-3-trifluoromethylpyridine varies, and large blanket orders can secure priority manufacturing windows.
Each shipment goes out with a comprehensive certificate of analysis and origin, full traceability for all critical raw materials, and documentation supporting method validation and compliance. Our technical team supports customer audits, custom purity needs, and regulatory filings. We can provide detailed process and analytical information upon request to help speed up customer project approvals.
As a direct manufacturer, we stand by our capacity and commitment. Questions about custom lot sizes, expedited batch manufacturing, and technical support for large-scale applications are met with direct answers from our product and operations teams. We understand that reliability and lead time transparency matter to your project’s bottom line, and that’s how we plan our operation—batch by batch, campaign by campaign.
In our export business, chemical regulations define every step, from raw materials to final product shipment. 2-Hydroxy-3-trifluoromethylpyridine is one product that demands particular care due to both its unique structure and global transport rules. Each time a batch leaves our factory, international chemical transport laws drive the process from packaging to paperwork. Our regulatory team regularly reviews updates from IATA, IMO, and chemical inventories in every target market, confirming that our documentation reflects the most recent requirements.
Packing this compound requires more than meeting basic guidelines. Its pyridine ring and trifluoromethyl group call for specialized handling to prevent leaks and cross-contamination during transit. Our production line only uses UN-approved drums or fluorinated containers, based on compatibility results from quality control. We affix compliant hazard labels and ensure all containers pass integrity tests before shipment, preventing regulatory delays and protecting downstream customers from unnecessary risks.
Every country applies its own approach to customs and border entry for organic building blocks like this. Some countries place this material under “controlled substances” for certain industrial processes, so we work closely with our agents to pre-clear shipments in these territories. Our shipping certificates include full chemical identity, batch traceability, and safety data sheets. If required under local rules, we prepare an export license or End-User Certificate, particularly for regulated research and pharma sectors. Exporting into the EU, USA, Japan, and China demands visibility into each country’s chemical inventory—so we maintain up-to-date registrations and, where needed, provide REACH or TSCA compliance documents with every shipment.
Getting the paperwork wrong isn’t an option. In the past, noncompliant paperwork resulted in customs holds or shipment returns, potentially damaging the product’s integrity. To avoid costly delays or regulatory issues, we synchronize our shipping documentation with current GHS hazard classifications, transport emergency instructions, and transportation restrictions—such as air cargo limitations or prohibition for certain UN hazard classes. We send copies of these documents with the cargo and to our freight partners digitally to streamline customs clearance.
Some ports and airlines flag shipments of organofluorine derivatives for closer inspection due to their potential environmental regulations. We address this by maintaining strong relationships with logistics partners who understand the nature of our chemical. Our technical team prepares emergency response instructions in several languages, following recommendations in the SDS and local transport rules. This reduces waste and minimises liability during accident investigations.
Having full transparency and readiness for inspection keeps our operations moving. We update our training for warehouse and logistics staff every quarter, based on evolving international rules. No batch departs our plant without passing through a multi-step checklist, covering packaging, labeling, paperwork, and regulatory pre-screening—quality control that reflects our commitment to safe, legal international chemical supply.
We keep sight of the end goal: deliver product safely, predictably, and within the legal guidelines that govern international chemical trade. Any customer importing 2-Hydroxy-3-trifluoromethylpyridine from our facility receives full documentation, regulatory compliance assurance, and the confidence that the product arrives in optimal condition—and with no customs surprises.
For product inquiries, sample requests, quotations or after-sales support, please feel free to contact me directly via sales3@ascent-chem.com, +8615365186327 or WhatsApp: +8615365186327
